Literature DB >> 6600175

Cell surface antigens and other characteristics of T cells regulating the antibody response to type III pneumococcal polysaccharide.

C E Taylor, D F Amsbaugh, P W Stashak, G Caldes, B Prescott, P J Baker.   

Abstract

The administration of a subimmunogenic dose of type III pneumococcal polysaccharide (SSS-III) produces an antigen-specific T cell-dependent phenomenon termed low-dose paralysis (immunologic unresponsiveness). This form of unresponsiveness can be transferred by spleen cells obtained 5 to 24 hr after priming, and the suppressive activity of the transferred cells is abolished by prior treatment with monoclonal anti-Lyt-2 and anti-I-J antibody in the presence of complement, indicating that suppression is mediated by a distinct subset of T cells (suppressor T cells). If primed spleen cells are transferred 24 to 72 hr after immunization with SSS-III, however, the resulting antibody response of immunized recipients is enhanced. Greater enhancement is noted when transferred cells, pretreated with monoclonal anti-Lyt-2 antibody plus complement to remove suppressor T cells, are used; such enhancement is attributed to amplifier T cells. These findings indicate suppressor T cells regulate the antibody response to SSS-III by influencing the expansion of SSS-III-specific clones of B cells as well as the expression of amplifier T cell activity; the latter causes B cells to proliferate further in response to SSS-III.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6600175

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

Review 1.  Regulation of magnitude of antibody response to bacterial polysaccharide antigens by thymus-derived lymphocytes.

Authors:  P J Baker
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

2.  Immunomodulatory activity of monophosphoryl lipid A in C3H/HeJ and C3H/HeSnJ mice.

Authors:  J R Hiernaux; P W Stashak; J L Cantrell; J A Rudbach; P J Baker
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

3.  T-cell modulation of the antibody response to bacterial polysaccharide antigens.

Authors:  C E Taylor; R Bright
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

4.  Genetic control of the humoral response to cryptococcal capsular polysaccharide in mice.

Authors:  F Dromer; P Yeni; J Charreire
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

5.  Specific immunological unresponsiveness to bacterial lipopolysaccharides develops in a cyclic manner.

Authors:  K L Elkins; P W Stashak; P J Baker
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

6.  Characterization of the immunodeficiency of RIIIS/J mice: immune response to polysaccharide antigens.

Authors:  J R Hiernaux; P J Baker; S J McEvoy; P W Stashak; M B Fauntleroy; E A Goidl
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

7.  Molecular structures that influence the immunomodulatory properties of the lipid A and inner core region oligosaccharides of bacterial lipopolysaccharides.

Authors:  P J Baker; T Hraba; C E Taylor; P W Stashak; M B Fauntleroy; U Zähringer; K Takayama; T R Sievert; X Hronowski; R J Cotter
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

8.  T-cell-dependent and T-cell-independent mechanisms of tolerance to glucuronoxylomannan of Cryptococcus neoformans serotype A.

Authors:  J B Sundstrom; R Cherniak
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

9.  Immunoregulation in experimental murine candidiasis: specific suppression induced by Candida albicans cell wall glycoprotein.

Authors:  E W Carrow; J E Domer
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

10.  Antigen-specific suppressor T cells respond to recombinant interleukin-2 and other lymphokines.

Authors:  C E Taylor; M B Fauntleroy; P W Stashak; P J Baker
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.